Extended-pulsed Fidaxomicin Bests Vancomycin for C Diff in Older People Extended-pulsed Fidaxomicin Bests Vancomycin for C Diff in Older People

Extended-pulsed fidaxomicin, delivering 20 doses over a longer time period after initial daily dosing, appears superior to standard-dose vancomycin for sustained cure of Clostridium difficile infection in patients age 60 or older, according to results from an open-label randomized trial.Reuters Health Information
Source: Medscape Infectious Diseases Headlines - Category: Infectious Diseases Tags: Gastroenterology News Source Type: news